Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmet Dogan

Showing results (231-240 of 371) with videos related to

Pageof 38
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 23, 2012
A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 regionJames R Cerhan, Zachary S Fredericksen, Anne J Novak, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 15, 2024
Characterizing Nodal Gamma-Delta T-Cell Lymphoma: Clinicopathological and Molecular InsightsMing Liang Oon, Jing Quan Lim, Jan Bosch-Schips, et al.
Blood|April 5, 2003
Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphomaHongtao Ye, Hongxiang Liu, Ayoma Attygalle, et al.
Lancet (London, England)|June 7, 2005
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantationKarl S Peggs, Ann Hunter, Rajesh Chopra, et al.
Blood Neoplasia|June 24, 2025
CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomasPaola Ghione, Kurt S Bantilan, Erel Joffe, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
Intratumoral T-cell composition predicts epcoritamab-based treatment efficacy in B-cell non-Hodgkin lymphomasLorenzo Falchi, Jahan Rahman, Lauren Melendez, et al.
The Journal of Molecular Diagnostics : JMD|December 28, 2018
Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell NeoplasmsMaria E Arcila, Wayne Yu, Mustafa Syed, et al.
Cancer Cell|June 15, 2013
SYK inhibition modulates distinct PI3K/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomasLinfeng Chen, Stefano Monti, Przemyslaw Juszczynski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2008
Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphomaJames R Cerhan, Wen Liu-Mares, Zachary S Fredericksen, et al.
Kidney International|January 24, 2014
Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosisSamar M Said, Sanjeev Sethi, Anthony M Valeri, et al.
Pageof 38

Showing results (231-240 of 371) with videos related to

Sort By:
Pageof 38
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 23, 2012
A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 regionJames R Cerhan, Zachary S Fredericksen, Anne J Novak, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 15, 2024
Characterizing Nodal Gamma-Delta T-Cell Lymphoma: Clinicopathological and Molecular InsightsMing Liang Oon, Jing Quan Lim, Jan Bosch-Schips, et al.
Blood|April 5, 2003
Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphomaHongtao Ye, Hongxiang Liu, Ayoma Attygalle, et al.
Lancet (London, England)|June 7, 2005
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantationKarl S Peggs, Ann Hunter, Rajesh Chopra, et al.
Blood Neoplasia|June 24, 2025
CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomasPaola Ghione, Kurt S Bantilan, Erel Joffe, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
Intratumoral T-cell composition predicts epcoritamab-based treatment efficacy in B-cell non-Hodgkin lymphomasLorenzo Falchi, Jahan Rahman, Lauren Melendez, et al.
The Journal of Molecular Diagnostics : JMD|December 28, 2018
Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell NeoplasmsMaria E Arcila, Wayne Yu, Mustafa Syed, et al.
Cancer Cell|June 15, 2013
SYK inhibition modulates distinct PI3K/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomasLinfeng Chen, Stefano Monti, Przemyslaw Juszczynski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2008
Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphomaJames R Cerhan, Wen Liu-Mares, Zachary S Fredericksen, et al.
Kidney International|January 24, 2014
Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosisSamar M Said, Sanjeev Sethi, Anthony M Valeri, et al.
Pageof 38